Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD
Science Advances · 13.02.2026 · 12 (7)
DOI: 10.1126/sciadv.aeb5665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 13.02.2026. Verfasst von Mingyi Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Phenome Institute, Research and Innovation Center, Shanghai Pudong Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Multifactorial Inheritance, Genetic Predisposition to Disease, Genomics, Fatty Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, The National Key Research and Development Program of China, the Shanghai Rising Star Program.
Abstract (Originalsprache)
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a globally prevalent disease, yet its genetic architecture remains incompletely characterized. We integrated genome-wide association study data from multiple cohorts totaling nearly 3 million individuals of European ancestry and applied cross-trait genomic modeling of hepatic fat and seven cardiometabolic traits to construct an MASLD-specific polygenic architecture. We identified 128 risk variants across 100 loci and prioritized 55 effector genes, including established (e.g., PNPLA3 and TM6SF2 ) and previously unreported candidates (e.g., NRXN3 and FRMD5 ). A phenome-wide scan of the MASLD polygenic risk score revealed broad associations spanning hepatic, cardiometabolic, renal, endocrine, and neuropsychiatric systems. Using a two-step, proteome-wide Mendelian randomization across >4900 plasma proteins, we identified potential mediators linking MASLD to disease. Validation in population-based cohort pinpointed seven proteins (e.g., FURIN, aldehyde dehydrogenase 2, and apolipoprotein M) mediating up to 50.6% of the cardiometabolic risk attributable to MASLD. Our findings delineate the polygenic architecture of MASLD, highlight its multisystem consequences, and nominate translational biomarkers for precision prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Human Phenome Institute, Research and Innovation Center, Shanghai Pudong Hospital, Fudan University, Shanghai, China.
- Fudan University Taizhou Institute of Health Sciences, Taizhou, China.
- State Key Laboratory of Genetics and Development of Complex Phenotypes, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Fudan University, Shanghai, China.
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
- Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, China.
ORCID-Profile: Mingyi Du, Huangbo Yuan, Tianhao Wu, Yanfeng Jiang, Li Jin, Tiejun Zhang, Zhenqiu Liu, Xingdong Chen
Förderung
- National Natural Science Foundation of China
- The National Key Research and Development Program of China
- the Shanghai Rising Star Program
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Du, M., Yuan, H., Wu, T., Jiang, Y., Suo, C., Jin, L., Zhang, T., Liu, Z., & Chen, X. (2026). Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD. Science Advances, 12(7). https://doi.org/10.1126/sciadv.aeb5665
Vancouver
Du M, Yuan H, Wu T, Jiang Y, Suo C, Jin L, et al. Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD. Science Advances. 2026;12(7). doi:10.1126/sciadv.aeb5665
BibTeX
@article{Du2026,
author = {Du, Mingyi and Yuan, Huangbo and Wu, Tianhao and Jiang, Yanfeng and Suo, Chen and Jin, Li and Zhang, Tiejun and Liu, Zhenqiu and Chen, Xingdong},
title = {Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {7},
doi = {10.1126/sciadv.aeb5665}
}
EUVIMED